Seattle Women’s: Health, Research, Gynecology
We offer a unique practice that integrates preventative care and medical treatment in addition to cutting-edge research. Our approach creates a standard of excellence in the specialized care of women.
The office is led by Robin Kroll, MD, a recognized leader in women’s healthcare and research.
Women’s Health
Our team of professionals is committed to providing you with up-to-date, personalized health care. We offer general, preventative, and specialized services for each stage of a woman’s life.
Clinical Research
Clinical research site specializing in women’s health issues. Over the past two decades, Robin Kroll, MD has served as a Principal Investigator for over 200 phase II, III and IV studies.
Help Others in Need
Through our Research with a Mission program, we make anonymous donations to charitable organizations on behalf of each volunteer who participates in a clinical research study.
Participate in Clinical Research!
Browse & Apply for currently enrolling clinical trials in Seattle, Washington. Learn more about your condition, receive access to new treatments, and help your community!
Understanding Endometriosis
Endometriosis is a pain…literally.The condition causes tissue that normally lines the inside of the uterus to grow outside your uterus. The tissue builds up with your menstrual cycle and sheds. IWith Endometriosis the tissue cannot shed normally, and can cause internal bleeding and scarring, leading to pain and potential fertility issues. Other symptoms can include painful
TherapeuticsMD Announces FDA Approval BIJUVA for Moderate to Severe Hot Flashes Due to Menopause
The FDA has just approved BIJUVA, an oral hormone therapy for moderate to severe vasomotor symptoms (also known as hot flashes) due to menopause. This is the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single capsule.Menopause is a naturally occurring transition for women with an average onset age
AJOVY FDA Approved for the Preventative Treatment of Migraines and is Now Available in Pharmacies
On September 14, 2018 the FDA approved AJOVY (fremanezumab-vfrm) injection for the preventative treatment of migraines in adults. The medication is an injectable calcitonin-gene-related peptide (CGRP) antagonist. This is the second anti-CGRP treatment that has recently been approved. This treatment is available in both quarterly and monthly injections. AJOVY can be self-administered or administered in
